HUP0003537A2 - Robinia pseudoacacia lektin és alkalmazásai - Google Patents

Robinia pseudoacacia lektin és alkalmazásai

Info

Publication number
HUP0003537A2
HUP0003537A2 HU0003537A HUP0003537A HUP0003537A2 HU P0003537 A2 HUP0003537 A2 HU P0003537A2 HU 0003537 A HU0003537 A HU 0003537A HU P0003537 A HUP0003537 A HU P0003537A HU P0003537 A2 HUP0003537 A2 HU P0003537A2
Authority
HU
Hungary
Prior art keywords
lectin
robinia pseudoacacia
robinia
disease
subject
Prior art date
Application number
HU0003537A
Other languages
English (en)
Inventor
Zsuzsanna Magdolna Bardocz
Neil William Fish
Richard Michael John Palmer
Arpad Janos Pusztai
Original Assignee
Alizyme Therapeutics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alizyme Therapeutics Limited filed Critical Alizyme Therapeutics Limited
Publication of HUP0003537A2 publication Critical patent/HUP0003537A2/hu
Publication of HUP0003537A3 publication Critical patent/HUP0003537A3/hu
Publication of HU225762B1 publication Critical patent/HU225762B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

A találmány tárgyát Robinia pseudoacacia<> (RPA) lektin alkalmazásaképezi a gyógyászatban, valamint a találmány tárgyát képezi egyizolált Robinia pseudoacacia lektin homopolipeptid, a Robiniapseudoacacia lektint tartalmazó készítmények, a Robinia pseudoacaciaalkalmazása betegség enyhítésére és/vagy kezelésére szolgálógyógyszerek előállításában, eljárás a betegség szabályozására,enyhítésére és/vagy kezelésére, valamint egy Robinia pseudoacacialektint tartalmazó étrend- vagy táplálékkiegészítő. Ó
HU0003537A 1997-08-29 1998-08-28 Robinia pseudoacacia lectin and its uses HU225762B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718413.9A GB9718413D0 (en) 1997-08-29 1997-08-29 Compositions
PCT/GB1998/002612 WO1999011278A1 (en) 1997-08-29 1998-08-28 Robinia pseudoacacia lectin and its uses

Publications (3)

Publication Number Publication Date
HUP0003537A2 true HUP0003537A2 (hu) 2001-02-28
HUP0003537A3 HUP0003537A3 (en) 2002-01-28
HU225762B1 HU225762B1 (en) 2007-08-28

Family

ID=10818276

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003537A HU225762B1 (en) 1997-08-29 1998-08-28 Robinia pseudoacacia lectin and its uses

Country Status (13)

Country Link
EP (1) EP1009418B1 (hu)
JP (1) JP2001514230A (hu)
CN (1) CN1170587C (hu)
AT (1) ATE214935T1 (hu)
AU (1) AU740353B2 (hu)
CA (1) CA2301848A1 (hu)
DE (1) DE69804466T2 (hu)
ES (1) ES2175752T3 (hu)
GB (1) GB9718413D0 (hu)
HU (1) HU225762B1 (hu)
NZ (1) NZ502971A (hu)
RU (1) RU2214259C2 (hu)
WO (1) WO1999011278A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
ATE501724T1 (de) * 2009-02-10 2011-04-15 Helvista Ag Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen
DE102010033458B4 (de) 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
KR101836679B1 (ko) 2015-08-19 2018-04-20 중앙대학교 산학협력단 아까시나무 잎 추출물을 유효성분으로 함유하는 ＩＬ－１β 관련 질환 예방 또는 치료용 약학조성물
RU2746424C1 (ru) * 2019-11-05 2021-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования «Астраханский государственный медицинский университет» Министерства здравоохранения Российской Федерации Способ выделения лектина бобов солодки гладкой
CA3227834A1 (en) * 2021-08-30 2023-03-09 Dhananjay Sathe Protein compositions for the treatment of inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280432A (ja) * 1985-06-05 1986-12-11 Asahi Chem Ind Co Ltd 抗腫瘍免疫細胞誘導方法
RU1799599C (ru) * 1990-11-16 1993-03-07 Львовский государственный медицинский институт Способ получени лектина

Also Published As

Publication number Publication date
RU2214259C2 (ru) 2003-10-20
HUP0003537A3 (en) 2002-01-28
HU225762B1 (en) 2007-08-28
WO1999011278A1 (en) 1999-03-11
EP1009418A1 (en) 2000-06-21
ATE214935T1 (de) 2002-04-15
DE69804466D1 (de) 2002-05-02
AU8876398A (en) 1999-03-22
GB9718413D0 (en) 1997-11-05
AU740353B2 (en) 2001-11-01
ES2175752T3 (es) 2002-11-16
EP1009418B1 (en) 2002-03-27
DE69804466T2 (de) 2002-11-14
CN1170587C (zh) 2004-10-13
JP2001514230A (ja) 2001-09-11
NZ502971A (en) 2003-02-28
CN1273533A (zh) 2000-11-15
CA2301848A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
IT1276783B1 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
ATE401892T1 (de) Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand
HUP0003265A2 (hu) Táplálékkompozíció felfekvéses fekélyek kezelésére
HUP0002196A2 (hu) Gyógyhatású táplálékkiegészítő cukorbetegek részére
AU5818994A (en) Application of carbamazepine and oxcarbazepine in the treatment of parkinson&#39;s disease and parkinsonian syndromes
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
MXPA04002714A (es) Uso de derivados de 2-oxo-1-pirrolidina para el tratamiento de trastornos del movimiento y de la discinesia.
ZA200501714B (en) Analogues of vitamin d
HUP0003537A2 (hu) Robinia pseudoacacia lektin és alkalmazásai
AUPR684801A0 (en) Supplement therapy
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
DE69715644D1 (de) VERWENDUNGEN VON alpha-LACTALBUMIN ZUSAMMENSETZUNGEN
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
ITRM20010494A0 (it) Integratore dietetico per la cura e la prevenzione della miopia.
UA26091C2 (uk) Основа для одержання препарату, який впливає hа ткаhинний обміh і модулює процеси імуhітету в біологічhих системах, та біологічhо активhа харчова добавка &#34;міпро-віт&#34;
Hashizume et al. Efficacy of “Kami-syouyou-san” for Male Chronic Pain Patients who Suffered from Pathological Character Change, So-called “Converted V pattern”, which is Typically Observed in Female Neurosis
UA27140C2 (uk) Препарат для лікуваhhя шлуhково-кишкових еhзимопатій
WO2002097119A3 (de) Verwendung des nachweises der expression von splice-varianten von gen21 für die diagnose und therapie von tumorerkrankungen
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees